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MICROENCAPSULATION OF RODENTICIDES1 
REX E. MARSII, Wildlife and Fisheries Biology, University of California, Davis, California 95616. 
Microencapsulation materials and techniques have 
advanced significantly over the past two decades. 
Encapsulation techniques are now used in a wide range of 
products from drugs to perfumes and food fragrances. As an 
industry, microencapsulation had its beginning in the research 
laboratories of National Cash Register (NCR) in Dayton, 
Ohio, in the late 1930s. It came into commercial use in 1954 
when carbonleM copy paper was introduced on the market. 
The entire field has made enormous progreM since that time. 
Microencapsulatioo and other associated controlled- release 
technology play an important role in time-release pesticides, 
giving them a delayed or longer action time. 
Microencapsulation in the simplest of terms comprises 
minute particles of the active product sealed by one of a 
variety of methods wi.thin a thin-walled sac or shell (protective 
coating) that is compo.5Cd of chemicals different from the 
active ingredient. Microcapsules generally measure from 5 to 
500 microns in size. As a process, microencapsulation has 
become a highly technical and complex scientific field unto 
itself and far beyond the intended scope of this paper. 
Over the past 20 years, several research papers have been 
published on the encapsulation or microencapsulation of 
rodenticides (fable 1 ), yet this means of improving rodenticide 
characteristics has not received broad or in-depth attention. 
Several factors are believed to have contributed to this. 
Harlen Shuyler appears to have been one of the first 
researchers in rodent control to explore encapsulation of 
rodenticides. To quote Cornwell (1970), "As far as is known, 
the first study into the encapsulation of rodenticides was 
undertaken by Shuyler (U.S. Patent 2,957,804 [1960))." 
Shuyler's work involved an enteric coating of arsenic and 
strychnine. Field results were leM than satisfactory, 
presumably due to incomplete coatings. No follow-up 
research was reported. 
Sometime later, research with encapsulated rodenticides 
was conducted by Greaves et al. (1968), selecting norbormide 
and alphacbloralose for their studies since these rodenticides 
were limited by their poor palatability or too rapid toxic 
action. Greaves and his colleagues found gelatin-encapsulated 
norbormide did not alter toxicity or the speed of action. Io 
rat feeding studies encapsulated norbormide was consumed in 
significantly larger amounts than baits prepared with the 
technical compound. 
Alphachloralose in an elhylcellulose encapsulation 
administered by gavage showed that the speed of action was 
related to d<:Mge and that encapsulation delayed apparent 
symptoms of poisoning and reduced the toxicity. With mice, 
bait containing encapsulated alphachloralose was more readily 
consumed and resulted in consistently higher mortality even 
though the encapsulated material was lower in toxicity. 
Greaves concluded from his studies that microencapsulation 
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warranted further studies in the field of rodcnticides and 
rodenticide formulation. 
Table 1. Microencapsulated rodenticides and repellents 
explored for use in vertebrate pest management with 
references. 
Chemicals 
Alpha-chlorohydrin 
Alphachloralose 
Arsenic 
Norbormide 
Strychnine 
Warfarin 
Zinc phosphide 
References 
Ericsson et al. 1971 
Grea\'es et al. 1968, Cornwell 1970 
Shuyler, cited by Cornwell 1970; 
U.S. Patent 1960 
Greaves et al. 1968, Cornwell 
1970, Jackson 1974 
Shuyler, cited by Cornwell 1970; 
Best et al. 1974; U.S. Patent 
1960 
Comwell 1970, Abrams & Hinkes 
1974 
Cornwell 1970, El-Sebae et al. 
1978, Anonymous 1986 
Peter Cornwell (1970) researched four rodenticides-
warfarin, zinc phosphide, norbormide, and alphachloralose--in 
encapsulated forms, and this represents the most extensive 
encapsulation tests of rodenticides to appear in print 
Cornwell studied about 150 different batches using varying 
phase ratios and coatings of ethyl cellulose, gelatin, 
gelatin/gum arabic, gelatin/carrageen, polyester wax, and 
polawax. These studies should be reviewed by those 
anticipating rodenticide encapsulation as they are the most 
comprehensive and revealing. The statement made by 
Cornwell (1970) best sums up this research: "Most have 
resulted in improved intake of active ingredient, but only 
rarely have they resulted in improved kill beyond the 
biological variation recognized to exist in groups of laboratory 
animals." 
There is a wide range of propo.5Cd reasons why it may be 
desirable to microencapsulate rodeoticide. These include the 
following: 
1. Taste-masking to increase acceptance. (fhis could 
greatly improve the kilt, permit higher bait 
10rigioally prepared for presentation at the Uaoniog Chemical Industry Research Institute, Dalian, Uaoning, P.R. China (October 
S-8, 1988). 
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concentrations to help overcome resistance problems, 
could do away with the need to prebait and reduce 
bail shynCM.) 
2. Odor-masking to increase acceptance. 
3. Delay the release of the toxicant in the 
gastrointestinal tract (slow adverse symptoms). 
4. Reduce the speed of detoxification by the rodent, 
permitting a lethal accumulation or d~ to be timely 
achieved, whereby increasing mortality rates (i.e., 
enhance toxicity). 
5. Modification of physical properties (e.g., converting 
liquid to solids). 
6. Stabilizing rodenticides that are sensitive to 
environmental conditions to prolong shelf life (e.g., 
light sensitive or hygroscopic compounds). 
7. Eliminate incompatibilities of bait-formulating 
ingredients. 
8. Prevent vaporization of volatile compounds (e.g., zinc 
phosphide). 
9. Reduce toxicity in handling rodenticides. 
10. Increase the physical bulk to make it more difficult 
to overformulate the rodenticide. 
11. C.oatings may secondarily be used as a means of 
incorporating desirable flavors, dyes, biological 
tracers, and chemical stabilizers. 
12. With a greater degree of efficacy, encapsulation may 
reduce the amount of pesticide needed in bait and/or 
used in the field, thus making the rodenticide 
environmentally more compatible. 
Taste and/or odor-masking are the research objectives 
most often pursued in rodenticide microencapsulation with 
delaying of the release of the toxicaot in the gastrointestinal 
tract being next in importance. The other reasons by 
themselves could rarely justify the additional ~t involved for 
the encapsulation proc.ess. Achieving one goal, however, 
could at the same time encompass one or more of the others. 
Some basic questions must be asked when embarking on 
microencapsulation of rodenticides. 
1. How finely does the species masticate its food? 
2. Where is the toxicant absorbed in the rodent's 
digestive tract? 
3. Moisture levels and pH values through 
gastrointestinal tract. 
4. How fast does the food move through the 
gastrointestinal tract? 
5. Bacterial or fermentation action associated with food 
proc.essing. 
In many cases detailed information is wanting. The 
mastication of food by rodents has not been studied in depth, 
and the amount of encapsulation damage resulting in the 
feeding proc.ess is unknown for the various types of coatings 
and capsule sizes. Jack.son (1974) reported that gelatin 
capsules of more than several hundred microns seemed to 
break in chewing by laboratory rats. Presumably mice would 
chew their food even finer. This information is of primary 
importance where taste or odor-masking is the primary 
objective. 
The site or sites of toxicant or toxic breakdown products 
absorption is not fully known for some rodenticides or 
potential rodenticides and is essential if encapsulation is for 
controlling onset of symptoms or toxi~is. The pH of the 
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rat stomach is reportedly low and that of the mouth and 
intestine on the basic side (pH>6.8) (Jack.son 1974). 
However, this may differ for the various species of pest 
rodents (e.g., ground squirrels vs. house mice). The time for 
passage of food through the various components of the 
gastrointestinal tract is not thoroughly known, and these times 
presumably differ for different food items and water 
availability. The physical forces exerted in the upper portion 
of the digestive tract may be influential in food and capsule 
breakdown. The role of intestinal microflora in food digestion 
and nutrient uptake may need special consideration in 
relationship to pharmacolcinetic studies. Along this same line, 
the significance of large caecums in some rodents to 
rodenticide pharmacological events is relatively unstudied. 
Conditions for encapsulation release may be made 
dependent upon moisture, pH, physical force, or combinations 
of these. the mechanism for release (complete or partial) is 
generally associated with leaching, erosion, rupture, or other 
such actions, depending on the composition of the protective 
coating (Luzzi 1970). The element of time also plays a 
significant role. 
The lack of this aforementioned biological data may be 
why so few past attempts at microencapsulation of 
rodenticides have been successful. 
This becomes more complicated if the rodenticide 
pro~d for encapsulation is to be used for several different 
rodent species, as the basic physical and physiological 
parameters may differ for each. It may become impossible to 
satisfy the collective criteria for more than one species of 
more distantly related species. Compromises may be possible 
but, if not, the ensuing encapsulated rodenticide may result in 
an enhanced specificity. Rodenticide specificity can be 
biologically desirable; on the contrary, a greater species 
specificity nearly always limits the marketing potential of the 
rodenticide, making it that much more difficult to achieve a 
favorable encapsulation ~I/benefit ratio. 
El-Sabae et al. (1978) compared three types of 
encapsulation (polyethylene glycol, nonsustained gelatin, and 
sustained gelatin) for zinc phosphide. The sustained gelatin 
encapsulation decreased the toxicity somewhat. 
Microencapsulation increased acceptance and palatability in 
white rats approaching two-fold when tested at a low level 
(0.033%) in baits. 
Occidental Chemical Corporation of the United States 
spent considerable time and research effort on the 
development of a coated zinc phosphide rodenticide that 
reportedly improves rodent acceptance and overcomes shyness 
caused by odor/taste (Anon. 1985). Studies in our 
laboratories (Marsh and Howard, unpubl.), however, indicate 
only minor improvements in bait acceptance and palatability 
with the coated material when compared with baits prepared 
with technical grade zinc phosphide. The Occidental Chemical 
Corp. has disc.ontinued for other reasons its sales of zinc 
phosphide and thus this new coated zinc phosphide was never 
marketed (Anon. 1985). 
Researchers in Korea (Chyun 1973) worked with paraffin 
wax and stearic acid as coating for zinc phosphide to slow its 
environmental degradation in the field. These tests were not 
microencapsulation as such but more of a matrix-type coating 
over bait particles. The paraffin coatings were reported to 
increase bait acceptance but they did not significantly enhance 
mortality in Norway rats. 
This is not unlike the paraffin-zinc phosphide coating 
used on cracked corn to make it more weather resistant when 
used for Microtus spp. control in apple orchards of New York 
(Caslick 1970). The work of Chyun (1973) and Caslick 
(1970), although interesting and with some of the same 
objectives, does not fall within the same category as 
microencapsulation but rather a matrix com~ition and 
slurry bait coating. Along this same line, strychnine suspended 
in methyl cellulose has been explored for dingo control in 
Australia by Best et al. (1974) with inconclusive results. 
Jackson (1974) discussed the potential value of 
encapsulated rodenticides and cellulose acetate phthalate 
(CAP) encapsulated norbormide. Bait consumption was 
enhanced and mortality increased when a relatively thick wall 
of CAP was produced. Thin-wall encapsulation was relatively 
ineffective in achieving the desired objectives. While 
promising, encapsulated norbormide never reached the 
marketing stage. 
Ericsson et al. (1971) evaluated alpha-chlorohydrin, a 
toxicant-sterilant, in encapsulated form using several 
preparations of vinyl resin-based and cellulose-based 
encapsulation materials. The vinyl resin-based encapsulation 
proved more acceptable to Norway rats than cellulose-based 
wall material. Although encapsulated alpha-chlorohydrin was 
consumed in considerably greater amounts than uncoated 
material, mortality was greatly decreased, suggesting that the 
active ingredient was not being released in adequate quantities 
and probably passed through the rats. 
The only rodenticide currently being sold is an 
encapsulated form of warfarin developed by the Wisconsin 
Alumni Research Foundation and marketed since 1974 under 
the registered trade mark TOX-HID®. 
Technical warfarin is processed in Wurster Air Suspension 
Coating equipment to produce discrete particles consisting of 
50% warfarin and 50% encapsulating material. The makeup 
of the coating material is not disclosed by the manufacturers. 
Rodenticide formulations containing encapsulated warfarin 
reportedly are 3 to 10 times more acceptable to rats in the 
laboratory than baits formulated of uncoated warfarin. Much 
of this research was reported on by Abrams and Hinkes 
(1974). 
Encapsulated warfarin is being produced for commercial 
sale by Hopkins Agricultural Chemical Co. (Madison, 
W1SCOnsin) and distributed to the rodenticide and pest control 
industry by Crown Chemicals (Division of Hopkins), Rockford, 
Illinois, and Prentiss Drug and Chemical Co., New York. It 
is marketed as a 0.5% concentrate in com starch to be 
formulated at a ratio of 1:19 in rodent bait to yield a 0.025% 
active warfarin finished bait. Several commercial ready-to-use 
rodent baits are formulated with encapsulated warfarin; 
however, there appears no major move in that direction. A 
good quality technical warfarin can be formulated into highly 
effective rodent baits without the need for encapsulation, 
hence relatively few bait formulators see the neces.sity to 
change. There is a lack of research data to prove that under 
field conditions encapsulated warfarin significantly enhances 
rodent control. 
Encapsulation may not be all ~itive, and the following 
~ible disadvantages must be considered: 
1. It may lead to an overload of rodenticide in the 
target animal that could increase potential secondary 
hazards to predators and scavengers. 
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2. May make some rodenticides more palatable to 
target species. 
3. May reduce natural emetic actions of rodenticides 
such as red squill and zinc phosphide, which serve as 
safeguards to some nontarget species. 
4. May make some rodenticides more toxic (enhance 
susceptibility) to nontarget species. 
5. Increase the toxicity of feces, which may be more 
hazardous to scavengers (greater environmental 
contamination). 
6. Slow environmental breakdown leading to greater 
environmental contamination from residual bait. 
Some of these were alluded to by Jackson (1974). 
The results of rodenticide microencapsulation research, 
although somewhat promising, have seldom led to a useful 
product. Only encapsulated warfarin has been marketed; 
however, zinc phosphide and oorbormide encapsulation 
received considerable research and showed some favorable 
promise. Unfortunately, neither progressed far enough to be 
highly effective. 
The potential benefits from microencapsulation of 
rodenticides has been demonstrated and thus remain a 
method by which some can be improved. Microencapsulation 
will undoubtedly play a greater role in the future when there 
is a greater biological need and economic impetus to move in 
that direction. 
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